Abstract | AIMS: We aim to modulate the renin-angiotensin system (RAS) by active immunization against angiotensin I/II, potentially by a novel type of peptide--'AngI-R' for the treatment of hypertension. METHOD: 27 spontaneous hypertensive rats (SHRs) were randomly divided into 3 groups (n=9). Effect of AngI-R on systolic blood pressure of SHRs was determined by its subcutaneous injection into SHRs with anti- angiotensin peptide AngI-R, captopril, physiological salt solution in the same schedule. Systolic blood pressure was monitored by tail-cuff arterial blood pressure measurement method and then calculated from the average of three measurements in each animal at a desired time (0, 4, 8, 16W). AngI, AngII and anti-AngI antibody were detected by ELISA and western blotting method. At the end, the pathologic changes in different organs of SHRs were observed. RESULT: The results exhibited a marked effect to lower the systolic blood pressure (-15 mmHg) of SHRs after subcutaneous injection with peptide AngI-R. The anti-hypertensive effect lasted for over 1 month. The level of AngI and AngII in the vaccinated group, after administration of AngI-R was lower than the one in the control group and the pre-administered group. The anti-AngI/II antibody titre in the experiment group significantly increased. CONCLUSION: The peptide AngI-R was able to decrease the blood pressure of SHRs. The peptide AngI-R induced an immune response to inhibit AngI and AngII, resulting in the decrease in blood pressure in SHRs.
|
Authors | Fang Hong, Wu Yong Quan, Rabindra Pandey, Shen Yi, Liu Chi, Li Zhan Xia, Ma Yuan, Lou Ming |
Journal | International journal of cardiology
(Int J Cardiol)
Vol. 148
Issue 1
Pg. 76-84
(Apr 01 2011)
ISSN: 1874-1754 [Electronic] Netherlands |
PMID | 19932924
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright © 2009 Elsevier Ireland Ltd. All rights reserved. |
Chemical References |
- Isoantibodies
- Vaccines, Subunit
- Angiotensin II
- Angiotensin I
|
Topics |
- Angiotensin I
(administration & dosage, antagonists & inhibitors, therapeutic use)
- Angiotensin II
(administration & dosage, antagonists & inhibitors, therapeutic use)
- Animals
- Blood Pressure
(drug effects, physiology)
- Hypertension
(pathology, prevention & control)
- Isoantibodies
(biosynthesis)
- Male
- Pilot Projects
- Rabbits
- Random Allocation
- Rats
- Rats, Inbred SHR
- Vaccines, Subunit
(administration & dosage, therapeutic use)
|